Chronic arsenicism with vitiligo, hyperthyroidism, and cancer.
Chronic arsenicism, which may result from medicinal administration of arsenic, can present typical cutaneous signs, and is associated with an increase in cutaneous and internal malignancies. Recognition of the cutaneous premalignant stigmata of chronic arsenicism can identify a patient at risk, and promote early detection and treatment of life-threatening cancers.
Bickley
L K
LK
Papa
C M
CM
D000368:Aged; D001151:Arsenic / Q000009:adverse effects*; D018053:Arsenites; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced*; D011188:Potassium / Q000009:adverse effects; D017680:Potassium Compounds; D012878:Skin Neoplasms / Q000139:chemically induced*; D014820:Vitiligo / Q000139:chemically induced*
D018053:Arsenites; D017680:Potassium Compounds; C009003:potassium arsenite solution; D001151:Arsenic; D011188:Potassium